Nurix Therapeutics, Inc. · NASDAQ:NRIX
Commodore Capital LP reported a 5.10% stake in Nurix Therapeutics, Inc. (Schedule 13G)
Event Feb 7, 2025 · Filed Feb 14, 2025
Commodore Capital LP reported a 5.10% stake in Nurix Therapeutics, Inc., 3,850,000 shares, as a passive investor on Feb 7, 2025. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 3,850,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| COMMODORE CAPITAL LP | 5.10% | 3,850,000 |
| Commodore Capital Master LP | 5.10% | 3,850,000 |
Source
Related
- Nurix Therapeutics, Inc.
- Commodore Capital LP
- Nurix Therapeutics, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Nov 14, 2025
- Form 4 · Hansen Gwenn · Oct 15, 2026
- Form 4 · Gregory Julia P · Oct 14, 2026
- Form 4 · Ring Christine · Oct 2, 2026
- Schedule 13G · Perceptive Advisors LLC · Sep 23, 2026
- Form 4 · Ring Christine · Sep 2, 2026